Found: 16
Select item for more details and to access through your institution.
Exploratory analysis of immunomodulatory factors identifies L1CAM as a prognostic marker in alveolar soft-part sarcoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241293951
- By:
- Publication type:
- Article
Metastatic Mucinous Cutaneous Carcinoma: Prolonged Response to Systemic Chemotherapy.
- Published in:
- European Journal of Clinical & Medical Oncology, 2011, v. 3, n. 2, p. 82
- By:
- Publication type:
- Article
SEOM-GETTHI clinical guideline for the practical management of molecular platforms (2021).
- Published in:
- Clinical & Translational Oncology, 2022, v. 24, n. 4, p. 693, doi. 10.1007/s12094-022-02817-8
- By:
- Publication type:
- Article
Receptor Tyrosine Kinase Inhibitors for the Treatment of Recurrent and Unresectable Bone Sarcomas.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 22, p. 13784, doi. 10.3390/ijms232213784
- By:
- Publication type:
- Article
Prognostic Value of Stem Cell Quantification in Stage II Colon Cancer.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0088480
- By:
- Publication type:
- Article
Recurrent Glioblastoma: A Review of the Treatment Options.
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4279, doi. 10.3390/cancers15174279
- By:
- Publication type:
- Article
Current Landscape of Immunotherapy for Advanced Sarcoma.
- Published in:
- Cancers, 2023, v. 15, n. 8, p. 2287, doi. 10.3390/cancers15082287
- By:
- Publication type:
- Article
A Growth Modulation Index-Based GEISTRA Score as a New Prognostic Tool for Trabectedin Efficacy in Patients with Advanced Soft Tissue Sarcomas: A Spanish Group for Sarcoma Research (GEIS) Retrospective Study.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 792, doi. 10.3390/cancers13040792
- By:
- Publication type:
- Article
A DNA damage repair gene‐associated signature predicts responses of patients with advanced soft‐tissue sarcoma to treatment with trabectedin.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 12, p. 3691, doi. 10.1002/1878-0261.12996
- By:
- Publication type:
- Article
Reply to: Extended adjuvant temozolomide in newly diagnosed glioblastoma: the more, the better?
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 9, p. 1616, doi. 10.1093/neuonc/noab125
- By:
- Publication type:
- Article
Reply to: "Extended adjuvant temozolomide in newly diagnosed glioblastoma: is more less?".
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 12, p. 1889, doi. 10.1093/neuonc/noaa209
- By:
- Publication type:
- Article
A phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond 6 cycles in patients with glioblastoma (GEINO 14-01).
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 12, p. 1851, doi. 10.1093/neuonc/noaa107
- By:
- Publication type:
- Article
Phase II trial of dacomitinib, a pan‒human EGFR tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 11, p. 1522, doi. 10.1093/neuonc/nox105
- By:
- Publication type:
- Article
SEOM-GEINO clinical guidelines for grade 2 gliomas (2023).
- Published in:
- Clinical & Translational Oncology, 2024, v. 26, n. 11, p. 2856, doi. 10.1007/s12094-024-03456-x
- By:
- Publication type:
- Article
HMGA1 regulates trabectedin sensitivity in advanced soft-tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) study.
- Published in:
- Cellular & Molecular Life Sciences, 2024, v. 81, n. 1, p. 1, doi. 10.1007/s00018-024-05250-y
- By:
- Publication type:
- Article
Phase II Trial of Palbociclib in Recurrent Retinoblastoma-Positive Anaplastic Oligodendroglioma: A Study from the Spanish Group for Research in Neuro-Oncology (GEINO).
- Published in:
- Targeted Oncology, 2020, v. 15, n. 5, p. 613, doi. 10.1007/s11523-020-00754-6
- By:
- Publication type:
- Article